These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17097181)

  • 21. Controlled release of avermectin from porous hollow silica nanoparticles: influence of shell thickness on loading efficiency, UV-shielding property and release.
    Li ZZ; Xu SA; Wen LX; Liu F; Liu AQ; Wang Q; Sun HY; Yu W; Chen JF
    J Control Release; 2006 Mar; 111(1-2):81-8. PubMed ID: 16388871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of silica carrier for controlled release of molsidomine: effect of preparation methods of silica matrixes and their composites with molsidomine on the drug release kinetics in vitro.
    Parfenyuk EV; Dolinina ES
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1038-45. PubMed ID: 25269886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gel core liposomes: an advanced carrier for improved vaccine delivery.
    Tiwari S; Goyal AK; Khatri K; Mishra N; Vyas SP
    J Microencapsul; 2009 Feb; 26(1):75-82. PubMed ID: 18608797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encapsulation and retention of decanoic acid in sol-gel-made silicas.
    Veith SR; Perren M; Pratsinis SE
    J Colloid Interface Sci; 2005 Mar; 283(2):495-502. PubMed ID: 15721925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic-sensitive silica nanospheres for controlled drug release.
    Hu SH; Liu TY; Huang HY; Liu DM; Chen SY
    Langmuir; 2008 Jan; 24(1):239-44. PubMed ID: 18052081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of synthesis and processing conditions on the release behavior and stability of sol-gel derived silica xerogels embedded with bioactive compounds.
    Morpurgo M; Teoli D; Palazzo B; Bergamin E; Realdon N; Guglielmi M
    Farmaco; 2005 Aug; 60(8):675-83. PubMed ID: 15979615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slow motion analysis of protein folding intermediates within wet silica gels.
    Shibayama N
    Biochemistry; 2008 May; 47(21):5784-94. PubMed ID: 18447365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Avidin bioconjugate with a thermoresponsive polymer for biological and pharmaceutical applications.
    Salmaso S; Bersani S; Pennadam SS; Alexander C; Caliceti P
    Int J Pharm; 2007 Aug; 340(1-2):20-8. PubMed ID: 17449207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The controlled release of tilmicosin from silica nanoparticles.
    Song M; Li Y; Fai C; Cui S; Cui B
    Drug Dev Ind Pharm; 2011 Jun; 37(6):714-8. PubMed ID: 21204738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Entrapment of highly active membrane-bound receptors in macroporous Sol-Gel derived silica.
    Besanger TR; Easwaramoorthy B; Brennan JD
    Anal Chem; 2004 Nov; 76(21):6470-5. PubMed ID: 15516143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of silica xerogels as carriers for drugs.
    Czarnobaj K
    Drug Deliv; 2008 Nov; 15(8):485-92. PubMed ID: 18798086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between physicochemical properties of doxorubicin-loaded silica/polydimethylsiloxane xerogel and in vitro release of drug.
    Prokopowicz M
    Acta Biomater; 2009 Jan; 5(1):193-207. PubMed ID: 18755642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug entrapment in silica microspheres through a single step sol-gel process and in vitro release behavior.
    Yilmaz E; Bengisu M
    J Biomed Mater Res B Appl Biomater; 2006 Apr; 77(1):149-55. PubMed ID: 16222698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles.
    He X; Nie H; Wang K; Tan W; Wu X; Zhang P
    Anal Chem; 2008 Dec; 80(24):9597-603. PubMed ID: 19007246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of drug release through the in situ assembly of stimuli-responsive ordered mesoporous silica with magnetic particles.
    Zhu S; Zhou Z; Zhang D
    Chemphyschem; 2007 Dec; 8(17):2478-83. PubMed ID: 17952885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of wettability and surface activity on release behavior of hydrophilic substances from lipid matrices.
    Koennings S; Berié A; Tessmar J; Blunk T; Goepferich A
    J Control Release; 2007 Jun; 119(2):173-81. PubMed ID: 17412444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectroscopic and electrochemical characterization of cytochrome c encapsulated in a bio sol-gel matrix.
    Deriu D; Pagnotta SE; Santucci R; Rosato N
    Biometals; 2008 Aug; 21(4):417-23. PubMed ID: 18163198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds.
    Margiotta N; Ostuni R; Teoli D; Morpurgo M; Realdon N; Palazzo B; Natile G
    Dalton Trans; 2007 Aug; (29):3131-9. PubMed ID: 17637988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
    Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
    Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo tissue response to resorbable silica xerogels as controlled-release materials.
    Radin S; El-Bassyouni G; Vresilovic EJ; Schepers E; Ducheyne P
    Biomaterials; 2005 Mar; 26(9):1043-52. PubMed ID: 15369693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.